Dresser S, Melnyk BM The effectiveness of conscious sedation on anxiety, pain, and procedural complications in young children. Pediatr Nurs. 2003 Jul-Aug;29(4):320-3. Review.
Hand D, Averley P, Lyne J, Girdler N Advanced paediatric conscious sedation: an alternative to dental general anaesthetic in the U.K. SAAD Dig. 2011 Jan;27:24-9.
Lourenço-Matharu L, Ashley PF, Furness S Sedation of children undergoing dental treatment. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD003877. doi: 10.1002/14651858.CD003877.pub4. Review.
Lourenço-Matharu L, Roberts GJ Oral sedation for dental treatment in young children in a hospital setting. Br Dent J. 2010 Oct 9;209(7):E12. doi: 10.1038/sj.bdj.2010.886.
Wilson S, Nathan JE A survey study of sedation training in advanced pediatric dentistry programs: thoughts of program directors and students. Pediatr Dent. 2011 Jul-Aug;33(4):353-60.
Wood M The safety and efficacy of intranasal midazolam sedation combined with inhalation sedation with nitrous oxide and oxygen in paediatric dental patients as an alternative to general anaesthesia. SAAD Dig. 2010 Jan;26:12-22.
Use of Sevoflurane, Midazolam and Ketamine in Children for Dental Sedation Treatment: Occurrence of Adverse Events
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
